Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

InMed Pharmaceuticals (INM) Other Gross PP&E Adjustments (2021 - 2025)

Historic Other Gross PP&E Adjustments for InMed Pharmaceuticals (INM) over the last 5 years, with Q2 2025 value amounting to $2.3 million.

  • InMed Pharmaceuticals' Other Gross PP&E Adjustments fell 1054.58% to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year decrease of 1054.58%. This contributed to the annual value of $2.3 million for FY2025, which is 1054.58% down from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Other Gross PP&E Adjustments of $2.3 million as of Q2 2025, which was down 1054.58% from $2.3 million recorded in Q1 2025.
  • Over the past 5 years, InMed Pharmaceuticals' Other Gross PP&E Adjustments peaked at $2.6 million during Q4 2023, and registered a low of $549195.0 during Q3 2021.
  • Over the past 5 years, InMed Pharmaceuticals' median Other Gross PP&E Adjustments value was $1.6 million (recorded in 2023), while the average stood at $1.9 million.
  • In the last 5 years, InMed Pharmaceuticals' Other Gross PP&E Adjustments soared by 15869.17% in 2022 and then plummeted by 1094.73% in 2025.
  • InMed Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $1.4 million in 2021, then rose by 0.25% to $1.4 million in 2022, then surged by 83.38% to $2.6 million in 2023, then fell by 8.99% to $2.4 million in 2024, then dropped by 1.71% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q2 2025, $2.3 million for Q1 2025, and $2.4 million during Q4 2024.